Skip to main content
OpenTrials

Clinical trial condition

Uveal Melanoma

Explore clinical trials studying Uveal Melanoma. Study availability and eligibility vary by location and protocol.

204 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Uveal Melanoma trial results

Active, not recruiting

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

NCT05907954

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Moores Cancer Center La Jolla, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 18 locations
View Trial Details
Active, not recruiting

Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors

NCT04336241

Conditions
Breast Diseases, Breast Neoplasms, Cancer, +25 more
Locations
  • Hospital Universitario d'Hebron Barcelona, Spain
  • Hospital Universitario HM Sanchinarro Madrid, Spain
  • Hospital Clinico de Valencia Valencia, Spain
  • The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Merseyside, United Kingdom
View Trial Details
Active, not recruiting

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

NCT05987332

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
View all 68 locations
View Trial Details
Active, not recruiting

A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma

NCT06717126

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations
  • SSD Tumori Rari e Melanoma Viale Orazio Flacco Bari, Italy
  • IRCSS National Cancer Institute, "G.Pascale" Foundation Dip. CORP-S di Ricerca ed Assistenziale Cute, Melanoma lmmunologia Oncologica Sperimentale e Terapie Innovative Naples, Italy
  • IRCSS Istituto Oncologico Veneto UOS Oncologia 2 del Melanoma Ospedale Busonera Padova, Italy
  • IRCCS Istituto Clinico Humanitas Rozzano, Italy
View all 16 locations
View Trial Details
Active, not recruiting

Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma

NCT06784648

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +27 more
Locations
  • Charité - Universitatsmedizin Berlin Berlin, Germany
  • University Hospital Essen Essen, Germany
  • University Hospital Heidelberg Heidelberg, Germany
  • University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg and Clinical Cooperation Unit Dermato-Oncology(G300) German Cancer Research Center(DKFZ) Mannheim, Germany
View Trial Details
Active, not recruiting

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

NCT05812027

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +43 more
Locations
  • HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 21 locations
View Trial Details

Related conditions